Combivair

Product Search

Combivair Product Information Leaflets
Brand Name:
Combivair
Generic Name:
Budesonide + Formoterol Fumarate

DESCRIPTION:

Combivair Rotacaps is a combination of budesonide, a potent glucocrticoid and formoterol, a selective long-acting beta -agonist. 2 Budesonide is a potent glucocorticoid that binds with high affinity to the glucocorticoid receptor. It has a high ratio of topical to systemic activity. Formoterol is a very potent long-acting beta -agonist with a high intrinsic 2 activity and a rapid onset of action.

COMPOSITION:

Combivair 200 Rotacaps: Each capsule contains: Budesonide B.P. 200 mcg Formoterol Fumarate (as Dihydrate) B.P. 6 mcg Combivair 400 Rotacaps: Each capsule contains: Budesonide B.P. 400 mcg Formoterol Fumarate (as Dihydrate) B.P. 6 mcg

INDICATIONS:

Combivair Rotacap is indicated in the regular treatment of asthma, where use of a combination (long acting beta -agonist and inhaled 2 corticosteroid) has been found to be appropriate. Symptomatic treatment of severe chronic obstructive pulmonary disease (COPD) with a history of repeated exacerbations despite regular therapy with long acting bronchodilators. It is not indicated for the relief of acute bronchospasm.

DOSAGE & ADMINISTRATION:

Capsules are intended for use through Revolizer or Rotahaler only and are not to be swallowed. Dosage is individual and adjusted according to disease severity. When control has been achieved, the dose should be titrated to the lowest effective dose, which could include Combivair Rotacap given once daily.

CONTRAINDICATIONS:

Combivair Rotacap is contraindicated in patients with a history of hypersensitivity to any of the component of the drug product.

PRESENTATION:

1. Combivair 200 Rotacaps: Blister pack of 3 X 10’s Rotacaps.
2. Combivair 400 Rotacaps: Blister pack of 3 X 10’s Rotacaps.

Patients should consult with their physician before taking any medicine.